首页> 美国卫生研究院文献>Clinical Medicine Insights: Blood Disorders >Mixed Phenotype Acute Leukemia with Two Immunophenotypically Distinct B and T Blasts Populations Double Ph+ Chromosome and Complex Karyotype: Report of an Unusual Case
【2h】

Mixed Phenotype Acute Leukemia with Two Immunophenotypically Distinct B and T Blasts Populations Double Ph+ Chromosome and Complex Karyotype: Report of an Unusual Case

机译:混合表型急性白血病与两个免疫表型不同的B和T爆炸人群双Ph +染色体和复杂核型:罕见病例的报告。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mixed phenotype acute leukemia (MPAL) is considered as a rare type of leukemia with an incidence of less than 4% of all acute leukemia based on the most recent 2008 WHO classification. Common subtypes are the B/myeloid and T/myeloid; B/T and trilineage MPAL being extremely rare. We present a case of a male in his 20s, whose peripheral blood smears showed 34% blast cells and bone marrow with 70% blasts. Immunophenotyping by multiparametric flow cytometry showed two populations of blasts, the major one with B-lineage and the minor one with T-lineage. Conventional karyotyping revealed complex karyotype with the presence of double Philadelphia chromosome (Ph+). BCR/ABL1 rearrangement was confirmed by fluorescent in situ hybridization (FISH) analysis. The BCR/ABL1 ES probe on interphase cells indicated p190 minor m-BCR/ABL fusion in 46% and a second abnormal clone with double Ph+ in 16% of the cells analyzed confirmed by reverse transcription-PCR (RT-PCR). The case was diagnosed as MPAL with double Philadelphia chromosome Ph+. The patient was treated with dasatinib, four cycle hyper CVAD/methotrexate cytarabin protocol, and allogeneic transplant. He is still alive in complete hematological, cytogenetic, and molecular remission. Mixed phenotype B/T acute leukemia is an extremely rare disease, particularly those with double Philadelphia chromosomes and clinically presents challenges in diagnosis and treatment.
机译:根据2008年WHO最新分类,混合表型急性白血病(MPAL)被认为是一种罕见的白血病,其发病率不到所有急性白血病的4%。常见的亚型是B /骨髓和T /骨髓; B / T和三系谱MPAL非常罕见。我们介绍了一例20多岁的男性,其外周血涂片显示34%的原始细胞,骨髓中70%的原始细胞。通过多参数流式细胞术进行的免疫分型显示出了两个母细胞群,主要的一个具有B谱系,次要的一个具有T谱系。常规核型分析显示复杂的核型,同时存在双费城染色体(Ph + )。通过荧光原位杂交(FISH)分析确认了BCR / ABL1重排。 BCR / ABL1 ES探针在间期细胞上显示p190小分子m-BCR / ABL融合占46%,第二个异常克隆中有16%的细胞具有双重Ph + ,通过逆转录PCR证实(RT-PCR)。该病例被诊断为费城染色体Ph + 双的MPAL。该患者接受了dasatinib,四周期高CVAD /甲氨蝶呤cytarabin方案和同种异体移植的治疗。他仍在完整的血液学,细胞遗传学和分子缓解方面还活着。混合表型B / T急性白血病是一种极为罕见的疾病,尤其是费城染色体双倍的那些,在临床上对诊断和治疗提出了挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号